Sensitivity and Specificity of Galectin-3 and Glypican-3 in Follicular-Patterned and Other Thyroid Neoplasms

Introduction: Diagnosing follicular-patterned thyroid neoplasm can be quiet challenging in some cases, where an immunohistochemical profiling becomes mandatory. Galectin-3 may be a helpful tool for classical PTC diagnosis, but it cannot be considered as a diagnostic marker of malignancy. Glypica...

Full description

Bibliographic Details
Main Authors: Dalia Rifaat Al-Sharaky, Sheren Fouad Younes
Format: Article
Language:English
Published: JCDR Research and Publications Private Limited 2016-03-01
Series:Journal of Clinical and Diagnostic Research
Subjects:
Online Access:https://jcdr.net/articles/PDF/7430/18375_CE[Ra1]_F(GH)_PF1(Ro_Om)_PFA(NC_AK)_PF2(PAG).pdf
_version_ 1828412655821389824
author Dalia Rifaat Al-Sharaky
Sheren Fouad Younes
author_facet Dalia Rifaat Al-Sharaky
Sheren Fouad Younes
author_sort Dalia Rifaat Al-Sharaky
collection DOAJ
description Introduction: Diagnosing follicular-patterned thyroid neoplasm can be quiet challenging in some cases, where an immunohistochemical profiling becomes mandatory. Galectin-3 may be a helpful tool for classical PTC diagnosis, but it cannot be considered as a diagnostic marker of malignancy. Glypican-3, in contrast, is not thoroughly studied in thyroid neoplasms. Aim: Determine the sensitivity and specificity of galectin-3 and glypican-3 in diagnosing thyroid carcinoma and follicularpatterned thyroid carcinoma. Materials and Methods: A retrospective study was conducted on archival blocks diagnosed from pathology department between 2010 and 2012 including 17 cases of follicular adenoma, 16 cases of Classic Papillary Thyroid Carcinoma (PTC), 6 cases of Follicular Variant of Papillary Thyroid Carcinoma (FVPTC), 3 cases of follicular carcinoma, 5 cases of medullary carcinoma and 1 case of Hürthle cell carcinoma. The nearby non neoplastic (normal) thyroid follicles present in both adenoma and carcinoma cases were also evaluated. Study Design: Evaluation of both galectin-3 and glypican-3 expression using standard immunohistochemical techniques. Statistical Analysis Used: Descriptive analysis of the variables and statistical significances were calculated by non-parametric chi-square test using the Statistical Package for the Social Sciences version 12.0 (SPSS). Results: Five (30%) and 4 (24%) out of the 17 studied follicular adenoma cases, were positively stained by galectin-3 and glypican-3 respectively, while 30 (97%) and 25 (81%) cases out of the studied 31 carcinoma cases were positively stained by galectin-3 and glypican-3 respectively. The sensitivity, specificity and diagnostic accuracy of galectin-3 vs. glypican-3 in discrimination between thyroid carcinoma and adenoma was 96.8%, 70.6%, and 87.5%vs. 81% 76.5% and 79% respectively. As for the discrimination between follicular-patterned thyroid carcinoma and follicular adenoma it was 90%, 71% and 78% vs. 90% 76.5% and 82%. Conclusion: Glypican-3 is more specific while galectin-3 is more sensitive in diagnosing thyroid carcinoma while glypican-3 is more specific than galectin-3 in discriminating follicularpatterned neoplasm.
first_indexed 2024-12-10T12:53:24Z
format Article
id doaj.art-2e3d464e565a48da91a571044988e4ea
institution Directory Open Access Journal
issn 2249-782X
0973-709X
language English
last_indexed 2024-12-10T12:53:24Z
publishDate 2016-03-01
publisher JCDR Research and Publications Private Limited
record_format Article
series Journal of Clinical and Diagnostic Research
spelling doaj.art-2e3d464e565a48da91a571044988e4ea2022-12-22T01:48:10ZengJCDR Research and Publications Private LimitedJournal of Clinical and Diagnostic Research2249-782X0973-709X2016-03-01103EC06EC1010.7860/JCDR/2016/18375.7430Sensitivity and Specificity of Galectin-3 and Glypican-3 in Follicular-Patterned and Other Thyroid NeoplasmsDalia Rifaat Al-Sharaky0Sheren Fouad Younes1Lecturer, Department of Pathology, Faculty of Medicine, Menoufia University, Egypt.Lecturer, Department of Pathology, Faculty of Medicine, Menoufia University, Egypt.Introduction: Diagnosing follicular-patterned thyroid neoplasm can be quiet challenging in some cases, where an immunohistochemical profiling becomes mandatory. Galectin-3 may be a helpful tool for classical PTC diagnosis, but it cannot be considered as a diagnostic marker of malignancy. Glypican-3, in contrast, is not thoroughly studied in thyroid neoplasms. Aim: Determine the sensitivity and specificity of galectin-3 and glypican-3 in diagnosing thyroid carcinoma and follicularpatterned thyroid carcinoma. Materials and Methods: A retrospective study was conducted on archival blocks diagnosed from pathology department between 2010 and 2012 including 17 cases of follicular adenoma, 16 cases of Classic Papillary Thyroid Carcinoma (PTC), 6 cases of Follicular Variant of Papillary Thyroid Carcinoma (FVPTC), 3 cases of follicular carcinoma, 5 cases of medullary carcinoma and 1 case of Hürthle cell carcinoma. The nearby non neoplastic (normal) thyroid follicles present in both adenoma and carcinoma cases were also evaluated. Study Design: Evaluation of both galectin-3 and glypican-3 expression using standard immunohistochemical techniques. Statistical Analysis Used: Descriptive analysis of the variables and statistical significances were calculated by non-parametric chi-square test using the Statistical Package for the Social Sciences version 12.0 (SPSS). Results: Five (30%) and 4 (24%) out of the 17 studied follicular adenoma cases, were positively stained by galectin-3 and glypican-3 respectively, while 30 (97%) and 25 (81%) cases out of the studied 31 carcinoma cases were positively stained by galectin-3 and glypican-3 respectively. The sensitivity, specificity and diagnostic accuracy of galectin-3 vs. glypican-3 in discrimination between thyroid carcinoma and adenoma was 96.8%, 70.6%, and 87.5%vs. 81% 76.5% and 79% respectively. As for the discrimination between follicular-patterned thyroid carcinoma and follicular adenoma it was 90%, 71% and 78% vs. 90% 76.5% and 82%. Conclusion: Glypican-3 is more specific while galectin-3 is more sensitive in diagnosing thyroid carcinoma while glypican-3 is more specific than galectin-3 in discriminating follicularpatterned neoplasm.https://jcdr.net/articles/PDF/7430/18375_CE[Ra1]_F(GH)_PF1(Ro_Om)_PFA(NC_AK)_PF2(PAG).pdfimmunohistochemistrythyroid adenomathyroid carcinoma
spellingShingle Dalia Rifaat Al-Sharaky
Sheren Fouad Younes
Sensitivity and Specificity of Galectin-3 and Glypican-3 in Follicular-Patterned and Other Thyroid Neoplasms
Journal of Clinical and Diagnostic Research
immunohistochemistry
thyroid adenoma
thyroid carcinoma
title Sensitivity and Specificity of Galectin-3 and Glypican-3 in Follicular-Patterned and Other Thyroid Neoplasms
title_full Sensitivity and Specificity of Galectin-3 and Glypican-3 in Follicular-Patterned and Other Thyroid Neoplasms
title_fullStr Sensitivity and Specificity of Galectin-3 and Glypican-3 in Follicular-Patterned and Other Thyroid Neoplasms
title_full_unstemmed Sensitivity and Specificity of Galectin-3 and Glypican-3 in Follicular-Patterned and Other Thyroid Neoplasms
title_short Sensitivity and Specificity of Galectin-3 and Glypican-3 in Follicular-Patterned and Other Thyroid Neoplasms
title_sort sensitivity and specificity of galectin 3 and glypican 3 in follicular patterned and other thyroid neoplasms
topic immunohistochemistry
thyroid adenoma
thyroid carcinoma
url https://jcdr.net/articles/PDF/7430/18375_CE[Ra1]_F(GH)_PF1(Ro_Om)_PFA(NC_AK)_PF2(PAG).pdf
work_keys_str_mv AT daliarifaatalsharaky sensitivityandspecificityofgalectin3andglypican3infollicularpatternedandotherthyroidneoplasms
AT sherenfouadyounes sensitivityandspecificityofgalectin3andglypican3infollicularpatternedandotherthyroidneoplasms